Avenue Therapeutics
is a New York-based pharmaceutical company that researches and develops therapies for the treatment of central nervous system disorders... Read moreAvenue Therapeutics
is a New York-based pharmaceutical company that researches and develops therapies for the treatment of central nervous system disorders... Read more
2015
PublicAcquired by InvaGen Pharmaceuticals, Inc.NASDAQATXI
News
May 08, 2026
Owler
Avenue Therapeutics, Inc.: Avenue Therapeutics's revenue had no change from Dec 2025 to Mar 2026
May 08, 2026
Benzinga
Avenue Therapeutics: Avenue Therapeutics Q1 EPS $(0.21) Up From $(...
Apr 06, 2026
Owler
Avenue Therapeutics, Inc.: Avenue Therapeutics's employee count changed from 2 in Dec 2024 to 1 in Dec 2025
Feb 23, 2026
GlobalNewswire
Press Release: Avenue Therapeutics : Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
Nov 14, 2025
Owler
Avenue Therapeutics, Inc.: Avenue Therapeutics's revenue had no change from Jun 2025 to Sep 2025
Nov 06, 2025
Seeking Alpha
Avenue Therapeutics: Axsome Therapeutics acquires Baergic Bio from Avenue Therapeutics
Aug 22, 2025
TipRanks
Avenue Therapeutics: Avenue Therapeutics Reports Positive Earnings Amid Challenges
Aug 14, 2025
Benzinga
Avenue Therapeutics: Avenue Therapeutics Q2 EPS $0.11 Up From $(6....
Apr 01, 2025
Owler
Avenue Therapeutics, Inc.: Avenue Therapeutics's employee count changed from 3 in Dec 2023 to 2 in Dec 2024
Nov 15, 2024
Seeking Alpha
Avenue Therapeutics: Avenue Therapeutics GAAP EPS of -$1.92 misses by $0.92
Avenue Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10